Adient (NYSE:ADNT – Get Free Report) has earned an average rating of “Hold” from the twelve research firms that are presently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.4444.
ADNT has been the topic of several research analyst reports. Stifel Nicolaus boosted their price objective on shares of Adient from $24.00 to $26.00 and gave the company a “buy” rating in a report on Friday, January 23rd. Wall Street Zen raised Adient from a “hold” rating to a “buy” rating in a research report on Friday, January 23rd. Morgan Stanley lifted their target price on Adient from $20.00 to $22.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. UBS Group lifted their target price on Adient from $30.00 to $32.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Adient in a research report on Wednesday, January 21st.
Check Out Our Latest Stock Report on Adient
Adient Stock Down 0.9%
Adient (NYSE:ADNT – Get Free Report) last issued its quarterly earnings data on Wednesday, February 4th. The company reported $0.35 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.16. The firm had revenue of $3.64 billion for the quarter, compared to analyst estimates of $3.45 billion. Adient had a negative net margin of 2.06% and a positive return on equity of 8.18%. Adient’s revenue was up 4.3% on a year-over-year basis. During the same period in the previous year, the firm earned $0.27 EPS. On average, sell-side analysts forecast that Adient will post 1.76 earnings per share for the current year.
Hedge Funds Weigh In On Adient
Several institutional investors have recently bought and sold shares of ADNT. Arrowstreet Capital Limited Partnership grew its position in Adient by 439.3% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,171,695 shares of the company’s stock valued at $22,801,000 after acquiring an additional 954,441 shares in the last quarter. Assenagon Asset Management S.A. grew its position in Adient by 921.9% in the 3rd quarter. Assenagon Asset Management S.A. now owns 812,329 shares of the company’s stock valued at $19,561,000 after acquiring an additional 732,837 shares in the last quarter. Engineers Gate Manager LP grew its position in Adient by 311.5% in the 4th quarter. Engineers Gate Manager LP now owns 636,138 shares of the company’s stock valued at $12,195,000 after acquiring an additional 481,538 shares in the last quarter. Invesco Ltd. grew its position in Adient by 38.6% in the 4th quarter. Invesco Ltd. now owns 1,599,937 shares of the company’s stock valued at $30,671,000 after acquiring an additional 445,343 shares in the last quarter. Finally, SG Americas Securities LLC grew its position in Adient by 5,271.0% in the 4th quarter. SG Americas Securities LLC now owns 419,531 shares of the company’s stock valued at $8,042,000 after acquiring an additional 411,720 shares in the last quarter. 92.44% of the stock is owned by institutional investors and hedge funds.
About Adient
Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.
Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.
Further Reading
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.
